Clinic and semiotics of digestive lesions with coronavirus SARS-CoV-2
Open Access
- 7 April 2021
- journal article
- research article
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 2,p. 20-26
Abstract
The article presents the results of the analysis of clinical features of gastroenterological manifestations of a new coronavirus infection (COVID-19) caused by the pathogen SARS-CoV-2. Taking into account the stage-by-stage system assessment of the experience of treating 1,180 patients in a multi-specialty hospital transformed into an infectious hospital, the most characteristic clinical manifestations of digestive damage by SARS-CoV-2 coronavirus are described. The article focuses on verification of changes in the digestive system, both at the stage of primary examination, and during etiotropic (in combination with hydroxychloroquine and azithromycin, interferon-alpha drugs), pathogenetic (in combination with corticosteroids, heparin drugs, according to indications - an interleukin-6 inhibitor) and symptomatic (antipyretics, antiemetics and antitussive drugs) therapy, carried out in accordance with Temporary guidelines of the Ministry of health of the Russian Federation “Prevention, diagnosis and treatment of new coronavirus infection Covid-19”. Directions for the development of algorithms for clinical and laboratory, instrumental and radiological diagnostics of changes in the digestive system in patients with COVID-19 are justified.Keywords
This publication has 14 references indexed in Scilit:
- Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020Cardiovascular Therapy and Prevention, 2020
- Immunological co-ordination between gut and lungs in SARS-CoV-2 infectionVirus Research, 2020
- New Coronavirus Infection (COVID-19) and Digestive SystemRussian Journal of Gastroenterology, Hepatology, Coloproctology, 2020
- Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysisMayo Clinic Proceedings, 2020
- Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019JAMA Network Open, 2020
- COVID-19 and the Digestive SystemAmerican Journal of Gastroenterology, 2020
- Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort studyThe Lancet Rheumatology, 2020
- Evidence for Gastrointestinal Infection of SARS-CoV-2Gastroenterology, 2020
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissuesInfectious Diseases of Poverty, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020